Interaction between the microbiome and TP53 in human lung cancer

Abstract Background Lung cancer is the leading cancer diagnosis worldwide and the number one cause of cancer deaths. Exposure to cigarette smoke, the primary risk factor in lung cancer, reduces epithelial barrier integrity and increases susceptibility to infections. Herein, we hypothesize that somat...

Full description

Bibliographic Details
Main Authors: K. Leigh Greathouse, James R. White, Ashely J. Vargas, Valery V. Bliskovsky, Jessica A. Beck, Natalia von Muhlinen, Eric C. Polley, Elise D. Bowman, Mohammed A. Khan, Ana I. Robles, Tomer Cooks, Bríd M. Ryan, Noah Padgett, Amiran H. Dzutsev, Giorgio Trinchieri, Marbin A. Pineda, Sven Bilke, Paul S. Meltzer, Alexis N. Hokenstad, Tricia M. Stickrod, Marina R. Walther-Antonio, Joshua P. Earl, Joshua C. Mell, Jaroslaw E. Krol, Sergey V. Balashov, Archana S. Bhat, Garth D. Ehrlich, Alex Valm, Clayton Deming, Sean Conlan, Julia Oh, Julie A. Segre, Curtis C. Harris
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Genome Biology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13059-018-1501-6
id doaj-c60baebde4ef47978781cd73c5e4c2ee
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author K. Leigh Greathouse
James R. White
Ashely J. Vargas
Valery V. Bliskovsky
Jessica A. Beck
Natalia von Muhlinen
Eric C. Polley
Elise D. Bowman
Mohammed A. Khan
Ana I. Robles
Tomer Cooks
Bríd M. Ryan
Noah Padgett
Amiran H. Dzutsev
Giorgio Trinchieri
Marbin A. Pineda
Sven Bilke
Paul S. Meltzer
Alexis N. Hokenstad
Tricia M. Stickrod
Marina R. Walther-Antonio
Joshua P. Earl
Joshua C. Mell
Jaroslaw E. Krol
Sergey V. Balashov
Archana S. Bhat
Garth D. Ehrlich
Alex Valm
Clayton Deming
Sean Conlan
Julia Oh
Julie A. Segre
Curtis C. Harris
spellingShingle K. Leigh Greathouse
James R. White
Ashely J. Vargas
Valery V. Bliskovsky
Jessica A. Beck
Natalia von Muhlinen
Eric C. Polley
Elise D. Bowman
Mohammed A. Khan
Ana I. Robles
Tomer Cooks
Bríd M. Ryan
Noah Padgett
Amiran H. Dzutsev
Giorgio Trinchieri
Marbin A. Pineda
Sven Bilke
Paul S. Meltzer
Alexis N. Hokenstad
Tricia M. Stickrod
Marina R. Walther-Antonio
Joshua P. Earl
Joshua C. Mell
Jaroslaw E. Krol
Sergey V. Balashov
Archana S. Bhat
Garth D. Ehrlich
Alex Valm
Clayton Deming
Sean Conlan
Julia Oh
Julie A. Segre
Curtis C. Harris
Interaction between the microbiome and TP53 in human lung cancer
Genome Biology
Lung cancer
Microbiome
TP53
Squamous cell carcinoma
Mutation
author_facet K. Leigh Greathouse
James R. White
Ashely J. Vargas
Valery V. Bliskovsky
Jessica A. Beck
Natalia von Muhlinen
Eric C. Polley
Elise D. Bowman
Mohammed A. Khan
Ana I. Robles
Tomer Cooks
Bríd M. Ryan
Noah Padgett
Amiran H. Dzutsev
Giorgio Trinchieri
Marbin A. Pineda
Sven Bilke
Paul S. Meltzer
Alexis N. Hokenstad
Tricia M. Stickrod
Marina R. Walther-Antonio
Joshua P. Earl
Joshua C. Mell
Jaroslaw E. Krol
Sergey V. Balashov
Archana S. Bhat
Garth D. Ehrlich
Alex Valm
Clayton Deming
Sean Conlan
Julia Oh
Julie A. Segre
Curtis C. Harris
author_sort K. Leigh Greathouse
title Interaction between the microbiome and TP53 in human lung cancer
title_short Interaction between the microbiome and TP53 in human lung cancer
title_full Interaction between the microbiome and TP53 in human lung cancer
title_fullStr Interaction between the microbiome and TP53 in human lung cancer
title_full_unstemmed Interaction between the microbiome and TP53 in human lung cancer
title_sort interaction between the microbiome and tp53 in human lung cancer
publisher BMC
series Genome Biology
issn 1474-760X
publishDate 2018-08-01
description Abstract Background Lung cancer is the leading cancer diagnosis worldwide and the number one cause of cancer deaths. Exposure to cigarette smoke, the primary risk factor in lung cancer, reduces epithelial barrier integrity and increases susceptibility to infections. Herein, we hypothesize that somatic mutations together with cigarette smoke generate a dysbiotic microbiota that is associated with lung carcinogenesis. Using lung tissue from 33 controls and 143 cancer cases, we conduct 16S ribosomal RNA (rRNA) bacterial gene sequencing, with RNA-sequencing data from lung cancer cases in The Cancer Genome Atlas serving as the validation cohort. Results Overall, we demonstrate a lower alpha diversity in normal lung as compared to non-tumor adjacent or tumor tissue. In squamous cell carcinoma specifically, a separate group of taxa are identified, in which Acidovorax is enriched in smokers. Acidovorax temporans is identified within tumor sections by fluorescent in situ hybridization and confirmed by two separate 16S rRNA strategies. Further, these taxa, including Acidovorax, exhibit higher abundance among the subset of squamous cell carcinoma cases with TP53 mutations, an association not seen in adenocarcinomas. Conclusions The results of this comprehensive study show both microbiome-gene and microbiome-exposure interactions in squamous cell carcinoma lung cancer tissue. Specifically, tumors harboring TP53 mutations, which can impair epithelial function, have a unique bacterial consortium that is higher in relative abundance in smoking-associated tumors of this type. Given the significant need for clinical diagnostic tools in lung cancer, this study may provide novel biomarkers for early detection.
topic Lung cancer
Microbiome
TP53
Squamous cell carcinoma
Mutation
url http://link.springer.com/article/10.1186/s13059-018-1501-6
work_keys_str_mv AT kleighgreathouse interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT jamesrwhite interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT ashelyjvargas interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT valeryvbliskovsky interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT jessicaabeck interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT nataliavonmuhlinen interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT ericcpolley interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT elisedbowman interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT mohammedakhan interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT anairobles interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT tomercooks interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT bridmryan interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT noahpadgett interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT amiranhdzutsev interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT giorgiotrinchieri interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT marbinapineda interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT svenbilke interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT paulsmeltzer interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT alexisnhokenstad interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT triciamstickrod interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT marinarwaltherantonio interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT joshuapearl interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT joshuacmell interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT jaroslawekrol interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT sergeyvbalashov interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT archanasbhat interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT garthdehrlich interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT alexvalm interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT claytondeming interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT seanconlan interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT juliaoh interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT julieasegre interactionbetweenthemicrobiomeandtp53inhumanlungcancer
AT curtischarris interactionbetweenthemicrobiomeandtp53inhumanlungcancer
_version_ 1725885910106505216
spelling doaj-c60baebde4ef47978781cd73c5e4c2ee2020-11-24T21:50:00ZengBMCGenome Biology1474-760X2018-08-0119111610.1186/s13059-018-1501-6Interaction between the microbiome and TP53 in human lung cancerK. Leigh Greathouse0James R. White1Ashely J. Vargas2Valery V. Bliskovsky3Jessica A. Beck4Natalia von Muhlinen5Eric C. Polley6Elise D. Bowman7Mohammed A. Khan8Ana I. Robles9Tomer Cooks10Bríd M. Ryan11Noah Padgett12Amiran H. Dzutsev13Giorgio Trinchieri14Marbin A. Pineda15Sven Bilke16Paul S. Meltzer17Alexis N. Hokenstad18Tricia M. Stickrod19Marina R. Walther-Antonio20Joshua P. Earl21Joshua C. Mell22Jaroslaw E. Krol23Sergey V. Balashov24Archana S. Bhat25Garth D. Ehrlich26Alex Valm27Clayton Deming28Sean Conlan29Julia Oh30Julie A. Segre31Curtis C. Harris32Laboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthResphera BiosciencesLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthCenter for Cancer Research Genomics Core, National Cancer Institute, National Institutes of HealthLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthDivision of Biomedical Statistics and Informatics, Mayo ClinicLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthDepartment of Educational Psychology, Baylor UniversityLaboratory of Experimental Immunology, Center for Cancer Research, National Cancer InstituteLaboratory of Experimental Immunology, Center for Cancer Research, National Cancer InstituteGenetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health BethesdaGenetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health BethesdaGenetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health BethesdaDepartment of Obstetrics and Gynecology, Mayo ClinicMicrobiome Laboratory, Mayo ClinicDepartment of Obstetrics and Gynecology, Mayo ClinicDepartment of Microbiology and Immunology, Center for Genomic Sciences, Institute of Molecular Medicine and Infectious Disease, Drexel University College of MedicineDepartment of Microbiology and Immunology, Center for Genomic Sciences, Institute of Molecular Medicine and Infectious Disease, Drexel University College of MedicineDepartment of Microbiology and Immunology, Center for Genomic Sciences, Institute of Molecular Medicine and Infectious Disease, Drexel University College of MedicineDepartment of Microbiology and Immunology, Center for Genomic Sciences, Institute of Molecular Medicine and Infectious Disease, Drexel University College of MedicineDepartment of Microbiology and Immunology, Center for Genomic Sciences, Institute of Molecular Medicine and Infectious Disease, Drexel University College of MedicineDepartment of Microbiology and Immunology, Center for Genomic Sciences, Institute of Molecular Medicine and Infectious Disease, Drexel University College of MedicineNational Human Genome Research Institute, National Institutes of HealthNational Human Genome Research Institute, National Institutes of HealthNational Human Genome Research Institute, National Institutes of HealthJackson LaboratoryNational Human Genome Research Institute, National Institutes of HealthLaboratory of Human Carcinogenesis, Center for Cancer, Research, National Cancer Institute, National Institutes of HealthAbstract Background Lung cancer is the leading cancer diagnosis worldwide and the number one cause of cancer deaths. Exposure to cigarette smoke, the primary risk factor in lung cancer, reduces epithelial barrier integrity and increases susceptibility to infections. Herein, we hypothesize that somatic mutations together with cigarette smoke generate a dysbiotic microbiota that is associated with lung carcinogenesis. Using lung tissue from 33 controls and 143 cancer cases, we conduct 16S ribosomal RNA (rRNA) bacterial gene sequencing, with RNA-sequencing data from lung cancer cases in The Cancer Genome Atlas serving as the validation cohort. Results Overall, we demonstrate a lower alpha diversity in normal lung as compared to non-tumor adjacent or tumor tissue. In squamous cell carcinoma specifically, a separate group of taxa are identified, in which Acidovorax is enriched in smokers. Acidovorax temporans is identified within tumor sections by fluorescent in situ hybridization and confirmed by two separate 16S rRNA strategies. Further, these taxa, including Acidovorax, exhibit higher abundance among the subset of squamous cell carcinoma cases with TP53 mutations, an association not seen in adenocarcinomas. Conclusions The results of this comprehensive study show both microbiome-gene and microbiome-exposure interactions in squamous cell carcinoma lung cancer tissue. Specifically, tumors harboring TP53 mutations, which can impair epithelial function, have a unique bacterial consortium that is higher in relative abundance in smoking-associated tumors of this type. Given the significant need for clinical diagnostic tools in lung cancer, this study may provide novel biomarkers for early detection.http://link.springer.com/article/10.1186/s13059-018-1501-6Lung cancerMicrobiomeTP53Squamous cell carcinomaMutation